Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHICL Infrastructure Regulatory News (HICL)

Share Price Information for HICL Infrastructure (HICL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 123.80
Bid: 123.60
Ask: 124.20
Change: 0.40 (0.32%)
Spread: 0.60 (0.485%)
Open: 123.20
High: 123.80
Low: 123.20
Prev. Close: 123.40
HICL Live PriceLast checked at -
HICL Infrastructure is an Investment Trust

To deliver a long-term, stable income to shareholders from a diversified portfolio of infrastructure investments positioned at the lower end of the risk spectrum.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Intention to undertake equity fundraising

31 Jan 2013 10:30

RNS Number : 7911W
HICL Infrastructure Company Ld
31 January 2013
 



HICL Infrastructure Company Limited (the "Company")

 

31 January 2013

 

Intention to undertake equity fundraising

 

The Board of HICL Infrastructure Company Limited is pleased to announce that it intends to proceed with a Placing, Open Offer and Offer for Subscription of Ordinary Shares (the "Issue") during the first quarter of this year.

 

In the Company's announcement of 17 December 2012, it was noted that the Company's ability to issue shares by way of 'tap' has been fully utilised for the time being, and that any further issue of shares on a non-pre-emptive basis would only be permitted following the requisite grant of authority by shareholders at a general meeting of the Company. The pipeline of potential new business remains healthy, and the Company's Investment Adviser is confident that further attractive investment opportunities will arise in the coming months. In light of the Group's current funding requirement of approximately £30m, and in anticipation of further investments being made, it is now the Board's intention to publish a prospectus in relation to the Issue, and to convene a general meeting for the purposes of seeking shareholder approval for the Issue.

 

As with previous formal equity fundraisings by the Company, the inclusion of an Open Offer will ensure that a portion of the Issue is reserved in the first instance exclusively for existing shareholders. Further details as to the precise timing and quantum of the Issue will be announced in due course. For indicative purposes, however, it is envisaged that a prospectus will be published in February, and that (subject to shareholder approval) the new Ordinary Shares will be issued and commence trading by the end of March. In terms of the size of the Issue, the Board will continue to observe the policy that the Company should not be cash positive to any material extent, and accordingly the Issue will be limited in size to the aggregate of (i) the Group's funding requirements at the time of publication of the prospectus and (ii) the consideration payable for further investments made or expected to be made by the Group (whether on a conditional or unconditional basis).

 

The Company has typically declared a second interim dividend in April or May of each year. In order to uphold the integrity of the cash cover on the Company's dividend, it is proposed that the record date in respect of the second interim dividend for the financial year ended 31 March 2013 should be brought forward ahead of the date of publication of the prospectus. Accordingly, subscribers for the new Ordinary Shares will not be entitled to this second interim dividend.

 

A further announcement giving full details of the Issue will be made at the time of publication of the prospectus.

 

 

Enquiries:

InfraRed Capital Partners Limited
020 7484 1800
Tony Roper
 
Keith Pickard
 
Erwan Fournis
 
Robin Hubbard
 
David Foot
 
 
 
Canaccord Genuity Limited
 
Sales Enquiries
 
Dominic Waters
020 7523 8473
Neil Brierley
020 7523 8478
Will Barnett
020 7523 8094
Robbie Robertson
020 7523 8474
Gavin Tooke
020 7523 8470
 
 
Corporate Enquiries
 
David Yovichic
020 7523 8361
Lucy Lewis
020 7523 8360
 
 
Tulchan Communications
020 7353 4200
Ed Orlebar
 
Rebecca Scott
 
 
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUAOKRONAAORR
Date   Source Headline
24th Nov 20217:00 amRNSInterim Results 6 Months Ended 30th September 2021
24th Nov 20217:00 amRNSPublication of Interim Report
17th Nov 20217:00 amRNSSecond Quarterly Interim Dividend
8th Nov 20217:00 amRNSAcquisition Activity
27th Oct 20217:00 amRNSNotice of Interim Results
13th Oct 20217:00 amRNSTransaction Activity
30th Sep 20217:00 amRNSChair Succession
27th Jul 20217:00 amRNSInterim Update Statement
21st Jul 202111:51 amRNSFirst Quarterly Interim Dividend
20th Jul 202112:00 pmRNSResult of AGM
13th Jul 202112:00 pmRNSAnnual General Meeting Details
9th Jul 20217:00 amRNSHICL signs first PPP LIBOR transition
9th Jun 20217:00 amRNSNotice of AGM
1st Jun 20217:00 amRNSPublication of HICL's 2021 Sustainability Report
26th May 20217:00 amRNSPublication of Annual Report
26th May 20217:00 amRNSAnnual Results for the year ended 31 March 2021
24th May 20217:00 amRNSHICL secures £400m ESG-linked SONIA facility
19th May 20213:15 pmRNSFourth Quarterly Interim Dividend
22nd Apr 20217:00 amRNSNotice of Annual Results
2nd Mar 20213:30 pmRNSDirector/PDMR Shareholding
2nd Mar 20213:19 pmRNSDirector/PDMR Shareholding
1st Mar 20217:00 amRNSDisposal of an investment
23rd Feb 20217:00 amRNSInterim Update Statement
17th Feb 20213:00 pmRNSThird Quarterly Interim Dividend
25th Nov 20207:01 amRNSPublication of Interim Report
25th Nov 20207:00 amRNSInterim Results Six Months Ended 30 September 2020
23rd Nov 20207:00 amRNSNew Long-dated Letter of Credit Facility
18th Nov 20203:00 pmRNSSecond Quarterly Interim Dividend
28th Oct 20207:00 amRNSNotice of Interim Results
9th Sep 20204:14 pmRNSHolding(s) in Company
14th Aug 20209:45 amRNSKepler Trust Intelligence: New Research
31st Jul 20207:00 amRNSTotal Voting Rights
22nd Jul 20203:00 pmRNSDirector/PDMR Shareholding
21st Jul 20203:08 pmRNSResult of Placing
21st Jul 20207:00 amRNSIncremental Acquisition
16th Jul 20207:00 amRNSInterim Update Statement
16th Jul 20207:00 amRNSProposed issue of equity
15th Jul 202011:25 amRNSFirst Quarterly Interim Dividend
14th Jul 202011:23 amRNSResult of AGM
12th Jun 202011:36 amRNSAnnual General Meeting Circular
10th Jun 202010:26 amRNSNew Investments
4th Jun 20202:05 pmRNSDirector Declaration
20th May 20207:01 amRNSPublication of Annual Report
20th May 20207:00 amRNSAnnual Financial Report
13th May 20203:00 pmRNSFourth Quarterly Interim Dividend
6th May 20207:00 amRNSNotice of Annual Results
28th Apr 20205:30 pmRNSDisclosure of Rights Attached to Equity Shares
27th Mar 202010:35 amRNSDirector/PDMR Shareholding
23rd Mar 20202:49 pmRNSDirector/PDMR Shareholding
20th Mar 20204:18 pmRNSUpdate and Investor Call

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.